No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Solid Biosciences Stock Jumps 11% Post-market on FDA Update
Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected
HealthTech Business Organisation Study: How to Organize Digital Health Businesses, Especially at Large Pharma and MedTech Companies - ResearchAndMarkets.com
RBC Capital Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $231
Biogen to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Healthcare Sector's 2024 Gainers and Losers: Intuitive Surgical, Boston Scientific Tops Chart